A major September 28, 2026 review shows how AI is combining gut microbiome, genetic, and metabolic data to generate truly individualized diet advice, though researchers caution the science hasn't yet caught up to consumer marketing claims.
Dexcom is adding AI-driven coaching features to its over-the-counter Stelo glucose sensor and expanding internationally, pushing continuous glucose monitoring further into mainstream wellness even as evidence for non-diabetics stays thin.
Deep Longevity launched Accrua on September 28, 2026, a consumer platform that uses AI to estimate biological age from routine blood work every quarter, entering an increasingly crowded longevity-testing market.
A study of more than 8,000 patients at Hospital Son Llatzer in Spain found that the BIAlert-Sepsis AI system cut hospital costs by up to 31 percent per patient, reduced ICU admissions and readmissions, and projected a 528 percent five-year return on investment.
A new study of a major Chinese food delivery platform found that an AI text-to-speech tool eliminated about a third of the hourly wage gap for deaf and hard-of-hearing couriers and cut negative customer ratings by two-thirds, researchers reported September 14, 2026.
Women's health startup Evvy closed an oversubscribed $40 million Series B on September 15, 2026 to expand EvvyAI, a machine-learning engine built on the world's largest vaginal microbiome dataset, starting with fertility diagnostics.
ARPA-H launched SPECTRA on September 17, 2026, a research program using AI to combine biological, behavioral, and clinical data in hopes of diagnosing autism earlier and tailoring care to each child's developmental trajectory.
A Yale School of Medicine study found that fine-tuning AI models on more than 13,000 patient records raised diagnostic accuracy from 48.6 to 54.8 percent, but also made the models far more likely to memorize and potentially leak sensitive patient details.
A multinational study of 963 stroke patients in Korea and the U.S. found that AI assistance reading plain, contrast-free brain CT scans raised clinicians' detection of dangerous large vessel occlusions, catching one additional case for every 18 scans reviewed.
The VA selected Abridge on September 22, 2026 for a five-year, $775.72 million enterprise contract to expand ambient AI documentation tools across veterans' health care, building on a pilot already running in more than 75 medical centers.